These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19234158)

  • 1. Suppression of autoimmune diabetes by soluble galectin-1.
    Perone MJ; Bertera S; Shufesky WJ; Divito SJ; Montecalvo A; Mathers AR; Larregina AT; Pang M; Seth N; Wucherpfennig KW; Trucco M; Baum LG; Morelli AE
    J Immunol; 2009 Mar; 182(5):2641-53. PubMed ID: 19234158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice.
    Perone MJ; Bertera S; Tawadrous ZS; Shufesky WJ; Piganelli JD; Baum LG; Trucco M; Morelli AE
    J Immunol; 2006 Oct; 177(8):5278-89. PubMed ID: 17015713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
    Li L; Yi Z; Wang B; Tisch R
    J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL-4-producing T cells and regulatory T cells.
    Li Z; Shi X; Liu J; Shao F; Huang G; Zhou Z; Zheng P
    FASEB J; 2019 Jul; 33(7):8241-8248. PubMed ID: 30916998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.
    Chou FC; Shieh SJ; Sytwu HK
    Eur J Immunol; 2009 Sep; 39(9):2403-11. PubMed ID: 19670381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
    Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes.
    Ling Q; Shen L; Zhang W; Qu D; Wang H; Wang B; Liu Y; Lu J; Zhu D; Bi Y
    Mol Med; 2022 Feb; 28(1):18. PubMed ID: 35123388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.
    Kiekhaefer CM; Weber B; Huggins M; Gorichanaz C; Nehring JA; DeLuca HF
    Clin Exp Immunol; 2011 Dec; 166(3):325-32. PubMed ID: 22059989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
    Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
    Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D supplementation induces CatG-mediated CD4
    Lai X; Liu X; Cai X; Zou F
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.
    Hill NJ; Van Gunst K; Sarvetnick N
    J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.
    Parsa R; Andresen P; Gillett A; Mia S; Zhang XM; Mayans S; Holmberg D; Harris RA
    Diabetes; 2012 Nov; 61(11):2881-92. PubMed ID: 22745325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.